Send me a link:

*Text messaging rates may apply.

 Dow Up0.36% Nasdaq Up0.71%

Cytokinetics, Incorporated (CYTK)

-NasdaqCM
4.34 Down 0.08(1.81%) 4:00PM EDT
|After Hours : 4.34 0.00 (0.00%) 4:29PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue 7,979   24,349   4,469   1,009  
Cost of Revenue -   -   -   -  
Gross Profit 7,979   24,349   4,469   1,009  
Operating Expenses
Research Development12,490  13,824  13,445  12,347  
Selling General and Administrative4,259  4,093  3,635  3,730  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (8,770) 6,432   (12,611) (15,068)
Income from Continuing Operations
Total Other Income/Expenses Net -  99  23   -  
Earnings Before Interest And Taxes(8,744)6,531  (12,588)(15,041)
Interest Expense -   -   -   -  
Income Before Tax(8,744)6,531  (12,588)(15,041)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(8,744)6,531  (12,588)(15,041)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (8,744) 6,531   (12,588) (15,041)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (8,744) 6,531   (12,588) (15,041)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.